BioLineRx (BLRX) Debt Ratio (2011 - 2026)

BioLineRx's Debt Ratio history runs 12 years deep, the most recent figure standing at 0.22 for Q4 2025.

• In Q4 2025, Debt Ratio fell 36.73% year-over-year to 0.22; the TTM figure through Dec 2025 stood at 0.22 (down 36.73% YoY), while the FY2025 annual figure was 0.22, down 36.73% from the prior year.
• Debt Ratio for Q4 2025 stood at 0.22, down from 0.25 in the prior quarter.
• The five-year high for Debt Ratio was 0.53 in Q3 2024, with the low at 0.01 in Q2 2022.
• The 5-year median for Debt Ratio is 0.17 (2024), against an average of 0.19.
• The sharpest annual moves came in 2021 and 2023: Debt Ratio plunged 72.53% in 2021, then soared 1215.01% in 2023.
• BioLineRx's Debt Ratio stood at 0.03 in 2021, then soared by 292.98% to 0.13 in 2022, then grew by 14.85% to 0.15 in 2023, then jumped by 125.91% to 0.35 in 2024, then plunged by 36.73% to 0.22 in 2025.
• Business Quant data shows BLRX's Debt Ratio at 0.22 in Q4 2025, 0.25 in Q3 2025, and 0.26 in Q2 2025.